Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Thoracic Outlet Syndrome Companies

Thoracic Outlet Syndrome (TOS) is a condition characterized by compression of the nerves or blood vessels in the thoracic outlet, resulting in symptoms such as pain, numbness, and weakness in the upper extremities. Treatment for TOS may involve a combination of physical therapy, medications, and in some cases, surgical intervention. Companies associated with thoracic outlet syndrome treatment may develop and provide relevant medical devices, medications, or therapies.

Thoracic Outlet Syndrome Market


Latest Thoracic Outlet Syndrome Companies Updates:

Medtronic receives FDA approval for its Intellis™ neurostimulation system for treating chronic neuropathic pain associated with TOS, offering a non-surgical option for pain management.

Abbott announces positive early data from a Phase 2 clinical trial of its DRG stimulator for treating nerve compression in TOS, demonstrating potential for improved nerve function and pain relief.

Vertos Medical Group secures additional funding to expand its clinical trial of the VERTIGO™ nerve decompression system for treating TOS, aiming to demonstrate its effectiveness in reducing symptoms and improving functional outcomes.

The Thoracic Outlet Syndrome Foundation (TOS Foundation) collaborates with medical institutions and researchers to advance TOS research and develop evidence-based treatment guidelines.

List of Thoracic Outlet Syndrome Key companies in the market:

  • Piramal Critical Care

  • Pfizer Inc.

  • Validus Pharmaceuticals LLC

  • GlaxoSmithKline plc

  • Novartis AG

  • Sanofi

  • Abbott

  • Bristol-Myers Squibb Company

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.